Elissa Berkowitz is a Hackensack, New Jersey based nurse practitioner. Active license number of Elissa Berkowitz is 26NJ00691800 in New Jersey. Her current practice location is 92 2nd St, Hackensack. Patients can reach her at 551-996-8647. Elissa Berkowitz is APN and her NPI number (Unique professional ID assigned by NPPES) is 1467806273. Elissa Berkowitz has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Elissa Berkowitz speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1467806273
NPI Enumeration Date:
18 Apr, 2016
NPI Last Update On:
22 Aug, 2024
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Elissa Berkowitz are as mentioned below.
License Number
Specialization
State
Status
26NJ00691800
New Jersey
Primary
F430956-1
Nurse Practitioner
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Elissa Berkowitz 92 2nd St, Hackensack, New Jersey
Zip:
07601-2191
Phone Number:
551-996-8647
Patients can reach Elissa Berkowitz at 92 2nd St, Hackensack, New Jersey or can call to book an appointment on 551-996-8647.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.